Results 131 to 140 of about 2,755,321 (217)

Knowledge and Attitudes of Indonesian General Practitioners Towards the Isoniazid Preventive Therapy Program in Indonesia. [PDF]

J Prev Med Public Health, 2022
Winardi W, Yudistira Nalapraya W, Sarifuddin S, Anwar S, Yufika A, Wibowo A, Fadhil I, Wahyuni Ms H, Arliny Y, Behtri Yanifitri D, Zulfikar T, Harapan H.   +11 more
europepmc   +1 more source

Isoniazid preventive therapy (IPT) defaulting: Who are responsible? [PDF]

, 2016
Session presented on Saturday, July 23, 2016 and Sunday, July 24, 2016: Purpose: Infection with human immunodeficiency virus (HIV) has been identified as the strongest risk factor in the reactivation of latent or new Mycobacterium tuberculosis infection ...
Okoli, Emmanuel Ikechukwu, Roets, Lizeth
core  

Liver Injury Following Isoniazid Preventive Therapy in HIV Patients Attending Halibet National Referral Hospital, Eritrea: A Prospective Cohort Study. [PDF]

Drugs Real World Outcomes, 2023
Russom M, Jeannetot DYB, Berhane A, Woldu HG, Stricker BH, Verhamme KMC.   +5 more
europepmc   +1 more source

Isoniazid preventive therapy completion and factors associated with non-completion among patients on antiretroviral therapy at Kisenyi Health Centre IV, Kampala, Uganda. [PDF]

PLoS One, 2023
Amanya I, Muhoozi M, Aruhomukama D, Ssebagereka A, Mugambe R.   +4 more
europepmc   +1 more source

Isoniazid Preventive Therapy for Prevention of Tuberculosis among People Living with HIV in Ethiopia: A Systematic Review of Implementation and Impacts. [PDF]

Int J Environ Res Public Health, 2022
Assefa DG, Zeleke ED, Bekele D, Ejigu DA, Molla W, Woldesenbet TT, Aynalem A, Abebe M, Mebratu A, Manyazewal T.   +9 more
europepmc   +1 more source

Int J STD AIDS [PDF]

We assessed the prevalence of isoniazid preventive therapy (IPT) uptake and explored factors associated with IPT non-uptake among people living with HIV (PLHIV) using nationally representative data from the Zimbabwe Population-based HIV Impact Assessment

core  

Integrating isoniazid preventive therapy into the fast-track HIV treatment model in urban Zambia: A proof-of -concept pilot project. [PDF]

PLOS Glob Public Health, 2023
Mukumbwa-Mwenechanya M, Mubiana M, Somwe P, Zyambo K, Simwenda M, Zongwe N, Kalunkumya E, Mwango LK, Rabkin M, Mpesela F, Chungu F, Mwanza F, Preko P, Bolton-Moore C, Bosomprah S, Sharma A, Morton K, Kasonde P, Mulenga L, Lingu P, Mulenga PL.   +20 more
europepmc   +1 more source

Timing of maternal isoniazid preventive therapy on tuberculosis infection among infants exposed to HIV in low-income and middle-income settings: a secondary analysis of the TB APPRISE trial. [PDF]

Lancet Child Adolesc Health, 2023
Gupta A, Singh P, Aaron L, Montepiedra G, Chipato T, Stranix-Chibanda L, Chanaiwa V, Vhembo T, Mutambanengwe M, Masheto G, Raesi M, Bradford S, Golner A, Costello D, Kulkarni V, Shayo A, Kabugho E, Jean-Phillippe P, Chakhtoura N, Sterling TR, Theron G, Weinberg A, IMPAACT P1078 TB APPRISE Study Team.   +22 more
europepmc   +1 more source

Outcomes of isoniazid preventive therapy in pregnant women living with HIV: A systematic review and meta-analysis. [PDF]

Int J Immunopathol Pharmacol
Shahid S, Karimi H, Ahmad B, Hafeez U, Ayalew BD, Abdullah.   +5 more
europepmc   +1 more source

Isoniazid preventive therapy-related adverse events among Malawian adults on antiretroviral therapy: A cohort study. [PDF]

Medicine (Baltimore), 2022
Tsirizani-Galileya L, Milanzi E, Mungwira R, Divala T, Mallewa J, Mategula D, Nampota N, Mwapasa V, Buchwald A, Laurens MB, Laufer MK, Van Oosterhout JJ.   +11 more
europepmc   +1 more source